Bio-Techne Corp at Morgan Stanley Global Healthcare Conference Transcript
Hi everybody. We'll get started. Good afternoon. My name is Valerie Dixon. I'm a Managing Director that covers the life sciences tools and diagnostics space in Morgan Stanley's investment banking team. Very excited to host Bio-Techne in our fireside chat this afternoon. We have Jim Hippel, the CFO; and David Clair, the Head of Investor Relations.
But first for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep.
With that out of the way, we can get started. So Jim, thanks for being here.
Thanks for having us.
We'd love to give you an opportunity to, if you don't mind, just spend a few minutes to tell folks who aren't familiar with the story. We should be by now, a little bit introduction and your latest thoughts on Bio
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
